These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16234338)

  • 1. Improving the design and analysis of high-throughput screening technology comparison experiments using statistical modeling.
    Woodward PW; Williams C; Sewing A; Benson N
    J Biomol Screen; 2006 Feb; 11(1):5-12. PubMed ID: 16234338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adopting a practical statistical approach for evaluating assay agreement in drug discovery.
    Sun D; Whitty A; Papadatos J; Newman M; Donnelly J; Bowes S; Josiah S
    J Biomol Screen; 2005 Aug; 10(5):508-16. PubMed ID: 16093560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical practice in high-throughput screening data analysis.
    Malo N; Hanley JA; Cerquozzi S; Pelletier J; Nadon R
    Nat Biotechnol; 2006 Feb; 24(2):167-75. PubMed ID: 16465162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Framework for the rapid optimization of soluble protein expression in Escherichia coli combining microscale experiments and statistical experimental design.
    Islam RS; Tisi D; Levy MS; Lye GJ
    Biotechnol Prog; 2007; 23(4):785-93. PubMed ID: 17592858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affinity-based screening techniques for enhancing lead discovery.
    Comess KM; Schurdak ME
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):411-6. PubMed ID: 15338950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative statistical parameter for high-throughput screening assay quality assessment.
    Sui Y; Wu Z
    J Biomol Screen; 2007 Mar; 12(2):229-34. PubMed ID: 17218666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further comparison of primary hit identification by different assay technologies and effects of assay measurement variability.
    Wu X; Sills MA; Zhang JH
    J Biomol Screen; 2005 Sep; 10(6):581-9. PubMed ID: 16103421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of statistical 'design of experiments' methods in drug discovery.
    Tye H
    Drug Discov Today; 2004 Jun; 9(11):485-91. PubMed ID: 15149624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evolution of microarrayed compound screening.
    Hoever M; Zbinden P
    Drug Discov Today; 2004 Apr; 9(8):358-65. PubMed ID: 15081963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel statistical approach for primary high-throughput screening hit selection.
    Yan SF; Asatryan H; Li J; Zhou Y
    J Chem Inf Model; 2005; 45(6):1784-90. PubMed ID: 16309285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding mechanisms of toxicity: insights from drug discovery research.
    Houck KA; Kavlock RJ
    Toxicol Appl Pharmacol; 2008 Mar; 227(2):163-78. PubMed ID: 18063003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved statistical methods for hit selection in high-throughput screening.
    Brideau C; Gunter B; Pikounis B; Liaw A
    J Biomol Screen; 2003 Dec; 8(6):634-47. PubMed ID: 14711389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compound set enrichment: a novel approach to analysis of primary HTS data.
    Varin T; Gubler H; Parker CN; Zhang JH; Raman P; Ertl P; Schuffenhauer A
    J Chem Inf Model; 2010 Dec; 50(12):2067-78. PubMed ID: 21073183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond the virtual screening paradigm: structure-based searching for new lead compounds.
    Schlosser J; Rarey M
    J Chem Inf Model; 2009 Apr; 49(4):800-9. PubMed ID: 19354328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lifetime earnings patterns, the distribution of future Social Security benefits, and the impact of pension reform.
    Bosworth B; Burtless G; Steuerle E
    Soc Secur Bull; 2000; 63(4):74-98. PubMed ID: 11641991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assay concordance between SPA and TR-FRET in high-throughput screening.
    von Ahsen O; Schmidt A; Klotz M; Parczyk K
    J Biomol Screen; 2006 Sep; 11(6):606-16. PubMed ID: 16760369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of diversity-based, high-throughput screening on drug discovery: "chance favours the prepared mind".
    Snowden M; Green DV
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):553-8. PubMed ID: 18600571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of virtual and high-throughput screening.
    Bajorath J
    Nat Rev Drug Discov; 2002 Nov; 1(11):882-94. PubMed ID: 12415248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.